August 1, 2026
Ratio Therapeutics
Ratio Therapeutics closed $70 million Series C financing to advance clinical development, bringing total capital raised to over $240 million.
- Round
- Series C
- Amount raised
- $70M
- Lead investor
- Insight Partners
- Industry
- Biotechnology
- Headquarters
- Boston
- Employees
- 11-50 employees
- Website
- —
- View profile →
Source: Google Alerts